Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 16, 2007. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically regarding the Deferred Investment Award Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific share transaction event rather than comprehensive financial performance.
Material Changes
The filing reports an increase in share interests for Dr. M M Slaoui under the Deferred Investment Award Plan. This increase resulted from the re-investment of dividends paid to shareholders on July 12, 2007, at a price of GBP 12.75 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory notification of a director's transaction in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: July 16, 2007
- Shareholder: Dr. M M Slaoui
- Transaction Type: Increase in interest via dividend re-investment
- Share Price: GBP 12.75
- Dividend Payment Date: July 12, 2007